Cetrotide and Progesterone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cetrotide (cetrorelix) and Progesterone (progesterone). Common drug interactions include ascites among females and foetal exposure during pregnancy among males.

The phase IV clinical study analyzes what interactions people have when they take Cetrotide and Progesterone. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Cetrotide?

Cetrotide has active ingredients of cetrorelix. eHealthMe is studying from 623 Cetrotide users. Check the latest studies of Cetrotide.

What is Progesterone?

Progesterone has active ingredients of progesterone. It is often used in menopause. eHealthMe is studying from 21,021 Progesterone users. Check the latest studies of Progesterone.

On Jul, 07, 2026

45 people who take Cetrotide and Progesterone together, and have interactions are studied.

Cetrotide and Progesterone drug interactions.

What are the common drug interactions of Cetrotide and Progesterone, by gender? *:

female:

Ascites (accumulation of fluid in the abdominal cavity)
Dyspnoea (difficult or laboured respiration)
Placenta praevia (a condition that occurs during pregnancy when the placenta is abnormally placed, and partially or totally covers the cervix)
Placental insufficiency
Breast tenderness
Drug hypersensitivity
Haematocrit increased
Hepatocellular injury (liver injury)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Immune system disorder

male:

Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
Heart valve calcification (deposits of calcium (calcification) in parts of the valve)
Hydrops foetalis (fetus characterized by an accumulation of fluid)
Pericardial effusion (fluid around the heart)
Vascular calcification (deposits of calcium in the blood vessels)

What are the common drug interactions of Cetrotide and Progesterone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abortion threatened (abortion with vaginal bleeding)
Delayed delivery
Injection site rash
Live birth
Maternal exposure during pregnancy (use of substance during pregnancy)
Premature rupture of membranes
Prolonged pregnancy

30-39:

Placental insufficiency
Haematocrit increased
Hepatocellular injury (liver injury)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Injection site urticaria (rash of round, red welts on the skin at injection site)
Pregnancy
Premature labour
Rash
Vomiting
Abortion spontaneous (naturally occurring miscarriage)

40-49:

Dizziness
Erythema (redness of the skin)
Lip swelling
Peripheral swelling
Sleep disorder

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Infertility Female: 13 people, 28.89%
Ovulation Induction: 6 people, 13.33%
Thyroid Dysfunction In Pregnancy: 3 people, 6.67%
Infertility: 3 people, 6.67%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 6.67%
Bleeding Disorders: 3 people, 6.67%
Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cetrotide and Progesterone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously